Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Cytel

Cytel is listed as a large business research supplier in the Scientist.com network, with 2 sites in 1 country and 1 service area.

View Cytel on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2
Countries 1

Logo Cytel, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Large business

Clinical Consulting

  • Biometrics Consulting Apply statistics and mathematics to drug discovery, clinical trials, and data analysis.
  • Biostatistics Consulting Apply statistical theory and mathematical principals to research

Clinical Trials

  • Bayesian Adaptive Trial Design Bayesian adaptive trial design allows real-time adjustments to clinical trials based on ongoing data analysis, enhancing flexibility and efficiency.
  • Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
  • Study/Site Feasibility Study Explore and test study practicality.
  • Synthetic Control Arm Creation Using RWD Using patient data from sources like electronic health records or claims databases to construct a comparator group for clinical trials, instead of enrolling a separate group of control patients.

Data Science/Bioinformatics

  • Biostatistical Design Use statistics to ensure appropriate pre-clinical and clinical study design.
  • Clinical Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
  • RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data
  • RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects
  • RWE/HEOR Market Analysis A process to understand how a drug is performing in the market and possible opportunities in the market
  • RWE/HEOR Software Tools Software designed to serve the needs of RWE/HEOR research groups.
Show all 55 services 43 more

Disease Models

  • Disease Simulation Modeling Disease Simulation Modeling

HEOR

  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.

Market Access

  • Academy of Managed Care Pharmacy (AMCP) Dossier Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
  • Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
  • Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
  • Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
  • Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Show all 8 in Market Access 2 more
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
  • Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

  • Data Monitoring Committee (DMC) / Statistical Analysis Center (SAC) Find organizations in order to ensure patient safety and scientific integrity
  • HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
  • Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.

Old Category HEOR, RWE, Market Access

  • Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
  • RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
  • RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
  • RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.

Real World Evidence & Data

  • Claims Data & Database Analysis Analysis of care cost and quality.
  • Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
  • Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
  • Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
  • Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
  • Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
Show all 17 in Real World Evidence & Data 11 more
  • Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
  • RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
  • RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
  • RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
  • Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
  • Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...

Scientific Data Services

  • Bayesian Statistics Extract information from data sets that are subject to error or noise to see unobserved possibilities.

Service areas:

Clinical

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Cambridge, Waltham 2 sites

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Cytel offers clinical research services and software to support clinical trial design and management.

Website
www.cytel.com

Source: Scientist.com supplier network, written by the supplier

Get the Cytel report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Cytel on Scientist.com

For prices, more details, or to contact Cytel, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.